{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:08:28Z","timestamp":1780103308863,"version":"3.54.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-CE09-0003"],"award-info":[{"award-number":["ANR-16-CE09-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-CE18-0033-02"],"award-info":[{"award-number":["ANR-20-CE18-0033-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l\u2019Enseignement sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.xjidi.2024.100273","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:59:14Z","timestamp":1711407554000},"page":"100273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Coencapsulation of Immunosuppressive Drug with Anti-Inflammatory Molecule in Pickering Emulsions as an Innovative Therapeutic Approach for Inflammatory Dermatoses"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3763-9986","authenticated-orcid":false,"given":"Maxime","family":"Sint\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0452-8098","authenticated-orcid":false,"given":"Petra","family":"Kovjenic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7884-4950","authenticated-orcid":false,"given":"Liasmine","family":"Haine (Hablal)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-1039","authenticated-orcid":false,"given":"Kevin","family":"Serror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-0038","authenticated-orcid":false,"given":"Mohamed","family":"Beladjine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8314-7427","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Parietti (Montcuquet)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6596-4268","authenticated-orcid":false,"given":"Marine","family":"Delagrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5322-1339","authenticated-orcid":false,"given":"Bertrand","family":"Ducos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4993-2461","authenticated-orcid":false,"given":"Jean-David","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7365-5943","authenticated-orcid":false,"given":"David","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5609-1478","authenticated-orcid":false,"given":"Maurice","family":"Mimoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-2497","authenticated-orcid":false,"given":"Armand","family":"Bensussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-1954","authenticated-orcid":false,"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-3778","authenticated-orcid":false,"given":"Nicolas","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-3282","authenticated-orcid":false,"given":"Laurence","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2024.100273_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1346-8138.2006.00022.x","article-title":"Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris","volume":"33","author":"Abe","year":"2006","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/0019-5154.139872","article-title":"Topical steroid-damaged skin","volume":"59","author":"Abraham","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib3","doi-asserted-by":"crossref","first-page":"13935","DOI":"10.1021\/acs.langmuir.8b02558","article-title":"Bare and sterically stabilized PLGA nanoparticles for the stabilization of pickering emulsions","volume":"34","author":"Albert","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.xjidi.2024.100273_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1523-1747.2002.01709.x","article-title":"Localization of calcineurin\/NFAT in human skin and psoriasis and inhibition of calcineurin\/NFAT activation in human keratinocytes by cyclosporin A","volume":"118","author":"Al-Daraji","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2004.06.015","article-title":"Skin penetration and distribution of polymeric nanoparticles","volume":"99","author":"Alvarez-Rom\u00e1n","year":"2004","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xjidi.2024.100273_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/eri.10.102","article-title":"Vitamin D: emerging roles in infection and immunity","volume":"8","author":"Bartley","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.xjidi.2024.100273_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122870","article-title":"Pickering emulsions stabilized with biodegradable nanoparticles for the co-encapsulation of two active pharmaceutical ingredients","volume":"637","author":"Beladjine","year":"2023","journal-title":"Int J Pharm"},{"issue":"Suppl. 4","key":"10.1016\/j.xjidi.2024.100273_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","article-title":"Maximizing patient adherence for optimal outcomes in psoriasis","volume":"25","author":"Bewley","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2024.100273_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.0105-1873.2005.00703.x","article-title":"Long-term repetitive sodium lauryl sulfate-induced irritation of the skin: an in\u00a0vivo study","volume":"53","author":"Branco","year":"2005","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.xjidi.2024.100273_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104700","article-title":"T-plastin expression downstream to the calcineurin\/NFAT pathway is involved in keratinocyte migration","volume":"9","author":"Brun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2024.100273_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/imm.12610","article-title":"Vitamin D immunoregulation through dendritic cells","volume":"148","author":"Bscheider","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.xjidi.2024.100273_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jps.2600840512","article-title":"Percutaneous absorption and dermal delivery of cyclosporin A","volume":"84","author":"Choi","year":"1995","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xjidi.2024.100273_bib14","article-title":"Interleukin 17 promotes expression of alarmins S100A8 and S100A9 during the inflammatory response of keratinocytes","volume":"11","author":"Christmann","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000098701","article-title":"Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation","volume":"20","author":"Cross","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.xjidi.2024.100273_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0160-4120(02)00032-6","article-title":"Biological activity and environmental impact of anionic surfactants","volume":"28","author":"Cserh\u00e1ti","year":"2002","journal-title":"Environ Int"},{"key":"10.1016\/j.xjidi.2024.100273_bib17","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1166\/jnn.2013.7789","article-title":"PLGA nanoparticles as delivery systems for protoporphyrin IX in topical PDT: cutaneous penetration of photosensitizer observed by fluorescence microscopy","volume":"13","author":"da Silva","year":"2013","journal-title":"J\u00a0Nanosci Nanotechnol"},{"key":"10.1016\/j.xjidi.2024.100273_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xjidi.2024.100273_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/0971-5916.195024","article-title":"PLGA-loaded nanomedicines in melanoma treatment: future prospect for efficient drug delivery","volume":"144","author":"Das","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.xjidi.2024.100273_bib20","doi-asserted-by":"crossref","first-page":"a015354","DOI":"10.1101\/cshperspect.a015354","article-title":"Psoriasis","volume":"4","author":"Di Meglio","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.xjidi.2024.100273_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1990.tb01480.x","article-title":"Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity","volume":"123","author":"Duncan","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib22","first-page":"74","article-title":"In\u00a0vivo effects of calcitriol on phenotypic and functional properties of dendritic cells","volume":"7","author":"Eftekharian","year":"2010","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","article-title":"Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice","volume":"53","author":"Gao","year":"2020","journal-title":"Biol Res"},{"key":"10.1016\/j.xjidi.2024.100273_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"Gibson","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib25","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in\u00a0vitro and in\u00a0vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xjidi.2024.100273_bib26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2024.100273_bib27","doi-asserted-by":"crossref","first-page":"31119","DOI":"10.1038\/srep31119","article-title":"Neutrophil extracellular trap formation is increased in psoriasis and induces human \u03b2-defensin-2 production in epidermal keratinocytes","volume":"6","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjidi.2024.100273_bib28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/157341311796196835","article-title":"Enhanced topical delivery of Cyclosporin-A using PLGA nanoparticles as carrier","volume":"7","author":"Jain","year":"2011","journal-title":"Curr Nanosci"},{"key":"10.1016\/j.xjidi.2024.100273_bib29","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.molonc.2015.02.004","article-title":"NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer","volume":"9","author":"Kaunisto","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.xjidi.2024.100273_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0923-1811(97)00609-9","article-title":"1,25-dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes","volume":"15","author":"Koizumi","year":"1997","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.xjidi.2024.100273_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","article-title":"Nanoparticles--an efficient carrier for drug delivery into the hair follicles","volume":"66","author":"Lademann","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xjidi.2024.100273_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mjd.2001.117046","article-title":"Treatment of psoriasis. Part 1. Topical therapy and phototherapy","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5021\/ad.2017.29.5.548","article-title":"Effects of VitabridC12 on skin inflammation","volume":"29","author":"Lee","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.colsurfa.2015.01.019","article-title":"Skin toxicity of surfactants: structure\/toxicity relationships","volume":"469","author":"L\u00e9mery","year":"2015","journal-title":"Colloids Surf Physicochem Eng ASp"},{"key":"10.1016\/j.xjidi.2024.100273_bib36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.11.008","article-title":"Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xjidi.2024.100273_bib37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.chemosphere.2004.10.031","article-title":"Acute toxicity and genotoxicity of five selected anionic and nonionic surfactants","volume":"58","author":"Liwarska-Bizukojc","year":"2005","journal-title":"Chemosphere"},{"key":"10.1016\/j.xjidi.2024.100273_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000102119","article-title":"Potential new indications of topical calcineurin inhibitors","volume":"215","author":"Luger","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2024.100273_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbamcr.2009.03.008","article-title":"Prokineticin 1 modulates IL-8 expression via the calcineurin\/NFAT signaling pathway","volume":"1793","author":"Maldonado-P\u00e9rez","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xjidi.2024.100273_bib41","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/17425247.2016.1182489","article-title":"Pickering emulsions: challenges and opportunities in topical delivery","volume":"13","author":"Marto","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xjidi.2024.100273_bib42","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/jcp.22951","article-title":"The inflammatory response of keratinocytes and its modulation by vitamin D: the role of MAPK signaling pathways","volume":"227","author":"Miodovnik","year":"2012","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.xjidi.2024.100273_bib43","doi-asserted-by":"crossref","first-page":"29080","DOI":"10.1039\/D1RA06087B","article-title":"Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects [published correction appears in RSC Adv 2022;12:21110]","volume":"11","author":"Mohd Nordin","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.xjidi.2024.100273_bib44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2567.2006.02460.x","article-title":"Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion","volume":"119","author":"Naranjo-G\u00f3mez","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.xjidi.2024.100273_bib45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xjidi.2024.100273_bib46","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.4049\/jimmunol.1701402","article-title":"Differentiation of Langerhans cells from monocytes and their specific function in inducing IL-22-specific Th Cells","volume":"201","author":"Otsuka","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.xjidi.2024.100273_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","article-title":"Understanding the prospective of nano-formulations towards the treatment of psoriasis","volume":"107","author":"Pradhan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xjidi.2024.100273_bib50","series-title":"Chapter 3. Pickering emulsions: history and fundamentals","first-page":"61","author":"Robin","year":"2022"},{"key":"10.1016\/j.xjidi.2024.100273_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17425247.2020.1758665","article-title":"Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis","volume":"17","author":"Saleem","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xjidi.2024.100273_bib53","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/exd.14149","article-title":"How can nanoparticle-based technologies revolutionize the topical therapy in psoriasis?","volume":"29","author":"Sindrilaru","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2024.100273_bib54","first-page":"1451","article-title":"Synthesis of PLGA nanoparticles of tea polyphenols and their strong in\u00a0vivo protective effect against chemically induced DNA damage [published correction appears in Int J Nanomedicine 2019;14:7001\u20137002]","volume":"8","author":"Srivastava","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xjidi.2024.100273_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","article-title":"Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel","volume":"254","author":"Sun","year":"2017","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xjidi.2024.100273_bib56","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jdermsci.2017.03.004","article-title":"Topical application of glycolic acid suppresses the UVB induced IL-6, IL-8, MCP-1 and COX-2 inflammation by modulating NF-\u03baB signaling pathway in keratinocytes and mice skin","volume":"86","author":"Tang","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.xjidi.2024.100273_bib57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/pharmaceutics13101539","article-title":"Does the vehicle matter? Real-world evidence on adherence to topical treatment in psoriasis","volume":"13","author":"Teixeira","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xjidi.2024.100273_bib58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/ndt\/gfg594","article-title":"In\u00a0vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression","volume":"19","author":"Tiefenthaler","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xjidi.2024.100273_bib59","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xjidi.2024.100273_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jdermsci.2016.12.003","article-title":"Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis","volume":"85","author":"Xiao","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.xjidi.2024.100273_bib61","first-page":"1073","article-title":"Lactic acid reduces LPS-induced TNF-\u03b1 and IL-6 mRNA levels through decreasing IKB\u03b1 phosphorylation","volume":"12","author":"Xu","year":"2013","journal-title":"J\u00a0Integr Agric"},{"key":"10.1016\/j.xjidi.2024.100273_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12964-022-00995-0","article-title":"Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase","volume":"20","author":"Yan","year":"2022","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.xjidi.2024.100273_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/derm.3.4.15027","article-title":"Antimicrobial implications of vitamin D","volume":"3","author":"Youssef","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.xjidi.2024.100273_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2010.09.037","article-title":"Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles","volume":"402","author":"Zhang","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xjidi.2024.100273_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00403-014-1446-x","article-title":"Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ)","volume":"306","author":"Zschocke","year":"2014","journal-title":"Arch Dermatol Res"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:43:32Z","timestamp":1778928212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026724000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2667026724000201"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100273","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coencapsulation of Immunosuppressive Drug with Anti-Inflammatory Molecule in Pickering Emulsions as an Innovative Therapeutic Approach for Inflammatory Dermatoses","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100273"}}